Skip to main content

Advertisement

Log in

CRHR1 Gene SNPs and Response to Systemic Corticosteroids in Indian Asthmatic Children During Acute Exacerbation

  • Original Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To determine association of corticotrophin releasing hormone receptor 1 (CRHR1) gene single nucleotide polymorphisms (SNPs), rs242939 (A>G) and rs242941 (G>T) with response to systemic corticosteroids in North Indian asthmatic children during acute exacerbation.

Methods

This was a hospital based cross-sectional study. Sixty-eight children aged 1 to 12y with acute exacerbation of asthma were included in the study. The study was approved by the institutional ethics committee and written informed consent was obtained from parents/guardians of recruited children. GINA guidelines 2008, were used for classification and treatment of acute exacerbation of asthma. As per the GINA guidelines 2008, children who had good response to injectable corticosteroid were classified as “Corticosteroid Responders” (CR). Rest of the children with incomplete or poor response to injectable corticosteroid were classified as “Corticosteroid Non Responders” (CNR).

Results

Among 68 hospitalized children, 45 (66.17 %) children were CR whereas 23 (33.83 %) children were CNR. On analyzing as dominant model, children with one or two copies of mutant allele of SNP rs242941 had statistically significant better response to systemic corticosteroid (OR = 5.00; 95 %CI = 1.32–19.64; p 0.013) as compared to children with no mutant allele.

Conclusions

Thus, CRHR1 gene SNP rs242941polymorphism is associated with better response to systemic corticosteroid during acute exacerbation of asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004;59:469–78.

  2. Awasthi S, Kalra E, Roy S, Awasthi S. Prevalence and risk factors of asthma and wheeze in school- going children in Lucknow, North India. Indian Pediatr. 2004;41:1205–10.

    PubMed  Google Scholar 

  3. National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics. J Allergy Clin Immunol. 2002;110:S141–219.

    Article  Google Scholar 

  4. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet. 2002;360:1313–22.

    Article  CAS  PubMed  Google Scholar 

  5. Lane SJ, Arm JP, Staynov DZ, Lee TH. Chemical mutational analysis of the human glucocorticoid receptor-α-expressing cells in the airways of fatal asthma. Am J Respir Cell Mol Biol. 1994;99:1130–7.

    Google Scholar 

  6. In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest. 1997;99:1130–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Drazen JM, Yandava CN, Dube L, Szczerback N, Hippensteel R, Pillari A, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet. 1999;22:168–70.

    Article  CAS  PubMed  Google Scholar 

  8. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med. 2000;162:75–80.

    Article  CAS  PubMed  Google Scholar 

  9. Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI. Asthma exacerbations during long term beta agonist use: influence of beta-2 adrenoceptor polymorphism. Thorax. 2000;55:762–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Christodoulopoulos P, Leung DY, Elliott MW, Hogg JC, Muro S, Toda M, et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma. J Allergy Clin Immunol. 2000;106:479–84.

    Article  CAS  PubMed  Google Scholar 

  11. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2006;117:522–43.

    Article  CAS  PubMed  Google Scholar 

  12. Polymeropoulos MH, Torres R, Yanovski JA, Chandrasekharappa SC, Ledbetter DH. The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22. Genomics. 1995;28:123–4.

    Article  CAS  PubMed  Google Scholar 

  13. Drolet G, Rivest S. Corticotropin-releasing hormone and its receptors: an evaluation at the transcription level in vivo. Peptides. 2001;22:761–7.

    Article  CAS  PubMed  Google Scholar 

  14. Dautzenberg FM, Hauger RL. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci. 2002;23:71–7.

    Article  CAS  PubMed  Google Scholar 

  15. Gupta S, Awasthi S, Sharma N, Agarwal S, Tripathi P. Association of CRHR1 gene polymorphisms (rs242941 and rs242939) with persistent asthma and its phenotype in Northern Indian asthmatic children: a cross-sectional study. Indian J Med Sci. 2012. In press.

  16. Awasthi S, Gupta S, Maurya N, Tripathi P, Dixit P, Sharma N. Environmental risk factors for persistent asthma in Lucknow. Indian J Pediatr. 2012;79:1311–7.

    Article  PubMed  Google Scholar 

  17. www.ginasthma.org. [homepage on internet]. Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute, US Department of Health and Human Services: National Institute of Health (NIH) Publication No 02-3659 (2008). Available from:: http://www.ginasthma.org/Guidelines/guidelines-resources.html

  18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann N Y Acad Sci. 1999;876:1–11.

  20. Funada M, Hara C, Wada K. Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. Eur J Pharmacol. 2001;430:277–81.

    Article  CAS  PubMed  Google Scholar 

  21. Sauvage M, Steckler T. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei – Potential implication for arousal and attention. Neuroscience. 2001;104:643–52.

    Article  CAS  PubMed  Google Scholar 

  22. Theoharides TC, Spanos C, Pang X, Alferes L, Ligris K, Letourneau R, et al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology. 1995;136:5745–50.

    CAS  PubMed  Google Scholar 

  23. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet. 2004;13:1353–9.

    Article  CAS  PubMed  Google Scholar 

  24. Rogers AJ, Tantisira KG, Fuhlbrigge AL, Litonjua AA, Lasky-Su JA, Szefler SJ, et al. Predictors of poor response during asthma therapy differ with definition of outcome. Pharmacogenomics. 2009;10:1231–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Dijkstra A, Koppelman GH, Vonk JM, Bruinenberg M, Schouten JP, Postma DS. Pharmacogenomics and outcome of asthma: no clinical application for long-term steroid effects by CRHR1 polymorphisms. J Allergy Clin Immunol. 2008;121:1510–3.

    Article  CAS  PubMed  Google Scholar 

  26. Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, et al. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD. Respirology. 2009;14:260–3.

    Article  PubMed  Google Scholar 

Download references

Contributions

SA: Responsible for conception, design, clinical examination, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content; SG: Responsible for conception, design, acquisition of data, clinical examination, analysis, interpretation of data and drafting the article; SAg: Responsible for genetic analysis and interpretation of data; NS: Responsible for laboratory work. All of them were responsible for final approval of the version to be published. SA will act as guarantor for this paper.

Conflict of Interest

None

Source of Funding

Indian Council of Medical Research provided funds to carry out this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sarika Gupta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Awasthi, S., Gupta, S., Agarwal, S. et al. CRHR1 Gene SNPs and Response to Systemic Corticosteroids in Indian Asthmatic Children During Acute Exacerbation. Indian J Pediatr 82, 781–786 (2015). https://doi.org/10.1007/s12098-015-1702-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-015-1702-x

Keywords

Navigation